Member Info for AB124

WTP,
You've hit the nail on the head.
Best to expect nothing and be pleasantly surprised than to be bitterly disappointed.
We all want Scancell to succeed so all we can really do is wait patiently for the Data.
Let's face it, Scancell as a Company want their platforms to shine so maybe we have to let them show it.
Nothing worse than to start believing the best ever news is going to be released today or some stated day in the future. Seems to me we have to sit and wait for the Company to tell us.
AIMO
Good weekend everybody.

EE bit of a mix of concepts now.
I'll just say that I agreed with your quote
""If retail investors on bulletin boards can possibly misunderstand something, then they will do so!"".
I'll apply that to the years long lack of understanding of timescales.
As to speculation, all holders of Shares are speculating, but that's completely different from the original discussion.
Looking forward to the RNSs that will radically change the SP. Whenever they arrive!
AIMO

EE
Agree Re RedMile and after their buyin I wrote that I felt that Scancell had become an Investment rather than a Punt.
The progress made has been massively accelerated as a result of their financial injection and by definition progress towards commercialisation has clearly been enhanced.
But there is still, and probably always will be, a lack of appreciation as to the speed at which SCLP shares will realise their true value and this overexpectation remains relentlessly applied as a motivant to the predictions of SP explosions we'll see in the near future.
Since I hold shares in Scancell I hope everything predicted occurs as soon a we're told it will by many posters, but with that sort of hope transferred to dates and times I fear that your point that,
"If retail investors on bulletin boards can possibly misunderstand something, then they will do so!"
remains in evidence. I suspect likely continue to add to the perhaps overoptimistic timescales and contents of news announcements when all we as investors can really do is sit back and wait for the company to tell us how things are going.
Quite simply nobody can say what will be included in RNS and when they will be released other than Scancell themselves, and to suggest otherwise is to highlight the reason that yesterday's RNS was received with disappointment by the Market.
AIMO

EE,
i completely agree with your comments as below,
"If retail investors on bulletin boards can possibly misunderstand something, then they will do so!

And, like the myths around the pandemic and its management by governments, once those wrong ideas are out there and in circulation, there is literally nothing that can be said to correct misunderstandings (which can be spectacular and entirely unwarranted by the actual facts in news items)."

I'm not too sure where you were placing that statement in the chronology of Scancell's "journey" but the point you make is so valid if taken in the (long term) overview.
Specifically,
"If retail investors on bulletin boards can possibly misunderstand something, then they will do so!"
Retail investors on this BB have spectacularly misunderstood "something" about Scancell since 2012 and that is the time it takes to move a platform such as Moditope from discovery to commercialisation.
There were posters suggesting that trials would be underway on Moditope by 2013. this was plainly a misunderstanding of the process of moving a product from R&D to Commercialisation.
Thus overexpectation has been a major feature of Scancell's progress on BBs and nothing has changed. Just look at the posts over the last 11 years, there's always the promise from posters of news just around the corner.
Well value enhancing news has been forthcoming but not at the pace that investors crave or many have promised in their posts here.
As you say EE, "If retail investors on bulletin boards can possibly misunderstand something, then they will do so!"
In my view FWIW your statement (I suspect aimed mainly at the most recent RNS) actually sums up very succinctly the problem many investors here have misunderstood since 2011/2012.
I believe Scancell has a good chance of succeeding , but maybe not as quickly (for maxium shareholder benefit as some might still think.
AIMO

Wikl, genuinely sorry to hear your news.
Hope you find something.

Chester,
Firstly I drew on your post simply because Chelsea 11 challenged me to produce such a post. I used your name on a historic search because I thought I remembered you had posted such a claim relatively recently and so I would not have to search for long by narrowing the field down to one poster. That idea proved to be correct and timely.
Secondly your response to me this morning ,
" AB124

You are a plonker...

Chester."

is hardly indicative of anything but a crass response, so please don't throw stones whilst rummaging about in your greenhouse.
Thirdly whether you like it or not your post that I reproduced fitted my point precisely.
Fourthly (and finally) you yourself posted in your last response ,
"My only error was not knowing that the other Cohort2 patients had different cancers where I assumed they were all very similar..." which again made my point for me, that it was not a correct assumption which made your December post fit the issue I was requested by Chelsea 11 to support this morning.
Chester you have already received an apology from Chelsea 11 this morning because his challenge of,
"AB - who specifically said that please?

No flannel - who?"

resulted in your post being resurrected.
Sorry but since you openly admit you got it wrong why on earth are you coming back now when your position is indefensible?
Sorry about this but you did dig it all up again.
AIMO

Ruck, sort of. The idea is that you buy awaiting the announcement of good news and when that GOOD NEWS is released you sell some. Since there's none of the extreme good news predicted in some quarters the sale of the "Rumour" would be a little premature. When the Data we all hope for arrives that should be an opportunity to really profit.
That said, I applaud your trade this morning but it's hopefully a mere practice run for the announcements yet to come.
AIMO

Scouse, please READ my post.
I posted,
"But posters here were saying that all patients would likely be responders. Not the case so..."
Who said anything about Scancell saying that? I certainly didn't.
I've made nothing up.

Sorry Ciaskin, see who you were answering!

Ciaskin
Should we publicise the fact that its taking months to replace our chairman? They're not queuing up are they?

Chester,
Thank Chelsea 11 for the exposure your (rather inaccurate) post has received.

Chillpill
But you're making my point for Management of Expectations precisely!
If one person starts talking about all patients responding (and others follow) then ANYTHING short of 100% is a DIASPPOINTMENT!
That is part of what's happened this morning.
Leave the "I'm clever, I know what will happen " out of it and then we get the results and everyone's happy.
These wild ideas that people have and post is the reason that Scancell can't possibly keep up with the (often) clueless posts we've seen over the years.
Try reading Bermudashorts, Burble and some of the other less "Screaming Headline" posters and then Non Scientific people might have a balanced idea of what is going on.
As it is scancell has been set completely unrealistic targets over many years.
Shame because it does the Company no good at all.
AIMO

Chelsea 11 ref your request (I assume to my)
"Chillpill
But posters here were saying that all patients would likely be responders. Not the case so..."
Here's one to be going on with.
chester18

Posted in: SCLP

Posts: 2,884

Price: 23.50

Strong Buy

RE: Evening All18 Dec 2022 19:35
With regards to our hopes and wishes for Scancell, I'm confident that ModiTope is working really well in the Immune system of our ModiFY Trial patients.

We have been very fortunate to have heard how the trial has impacted on one particular patient. Shareholders do not usually know any information prior to a company announcement. In this case we know for an absolute fact that moditope has worked to an outstanding level but at this point we only know it is in just one person. I honestly believe that in the next two days we will hear that the other Cohort 2 patients are seeing the same life changing results.

What's more we will also hear by the end of the year that the SCiB1 + Ci Trial is proving very positive as well.

Maybe not first thing tomorrow morning but by 2.00pm Tuesday we should know exactly where we are at regards to the ModiFY trial ..

All the best

Chester.....
Not keen on quoting others verbatim but you did ask me.

Chillpill
But posters here were saying that all patients would likely be responders. Not the case so... Disappointment.
Yet again,
Management of expectations rules.
BB was told all would melt,
Reality
Not the case
AIMO

Think it's where the MM's see the market rather than anyone wanting to sell. All things are relative and many who believed that Scancell's interims (and there's quite a few who did think that) would be glittering and wonderful will be disappointed. The MMs see the orders coming and run away from buying them. Hence the drop. Sadly there's nothing today that looks better than yesterday. That's what its all about. If there was something to say there's 100% responders then that would lift the SP. As it is there's nothing like that.
Seems reasonable to expect some SP weakness until Investors regain their composure.
Simple really.
AIMO

Really?

Allan, I'll agree that the lower the SP the more likely an offer!

Chelsea11
No, not the end of the world, just a disappointment for some, but not surprising to others.
That's a market I believe.
So those who predicted wonders of revelations with the Interims are disappointed, those who thought otherwise are seeing what they expected.
One day I'm sure the RNS will arrive which will send the SP stratospheric but sadly this set of Interims were not the ones.
Perhaps there'll be another RNS today? At the moment though the Market's underwhelmed.
AIMO

Well Del
With the bid around 21.5p quite a few don't share your view.
It's all about expectations, and if we'd started with the idea of waiting for results we'd possibly been starting from a lower base and seeing a rise this morning. asit is we've had experts posting everything's wonderful for weeks and with the fall of one world beater (covidity) and also not wevery patient in every trial respondining as the first, things don't seem so good as was being posted a couple of days back.
AIMO

Konar,
I was discussing Covidity in the context of Allan's post about all platforms.
Scancell say about Covidity,
"The COVIDITY programme, focusing on the Company's novel COVID-19 vaccine candidates SCOV1 and SCOV2, recently completed dosing in South Africa and we expect to report safety and immunogenicity data in Q1 2023. As previously disclosed, given the large size of later stage trials and the competitive landscape the Company does not intend to do further trials and will focus its resources on the oncology platforms....."
That is not all platforms being good is it?
So I'm simply saying that expert posters on this forum disagree with the Company who have decided against continuing with the answer to all pandemics.
It's only one but please stop puffing up everything that Scancell have. Let the Data do the talking . There's no point in building expectations that are unlikely to be supported by RNS. That is EXACTLY what many on here have been doing for years.
Let the Company's DATA do the talking, not uninformed rhetoric as has been the case with Covidity!
AIMO